Bevacizumab in Combination With Oxaliplatin, Fluorouracil, and Leucovorin (FOLFOX4) for Previously Treated Metastatic Colorectal Cancer: Results From the Eastern Cooperative Oncology Group Study E3200Bruce J. Giantonio, Al B. Benson, Edith P. Mitchell et al.|Journal of Clinical Oncology|2007Cited by 2.3k
Oxaliplatin, Fluorouracil, and Leucovorin for Patients With Unresectable Liver-Only Metastases From Colorectal Cancer: A North Central Cancer Treatment Group Phase II StudySteven R. Alberts, John H. Donohue, Daniel J. Sargent et al.|Journal of Clinical Oncology|2005Cited by 541
High-dose bevacizumab improves survival when combined with FOLFOX4 in previously treated advanced colorectal cancer: Results from the Eastern Cooperative Oncology Group (ECOG) study E3200Bruce J. Giantonio, Al B. Benson, Paul J. Catalano et al.|Journal of Clinical Oncology|2005Cited by 344
Bevacizumab in Combination With Oxaliplatin, Fluorouracil, and Leucovorin (FOLFOX4) for Previously Treated Metastatic Colorectal Cancer: Results From the Eastern Cooperative Oncology Group Study E3200Bruce J. Giantonio, Al B. Benson, Paul J. Catalano et al.|Journal of Clinical Oncology|2023Cited by 163